(Q43996148)

28 November 2017

title

Vitamin D activates the Nrf2-Keap1 antioxidant pathway and ameliorates nephropathy in diabetic rats (English)

1 reference

28 November 2017

0 references

1 reference

Sohei Kitazawa

6

0 references

Masafumi Fukagawa

object named as

Masafumi Fukagawa

9

0 references

author name string

Kentaro Nakai

1

1 reference

28 November 2017

Hideki Fujii

2

1 reference

28 November 2017

Keiji Kono

3

1 reference

28 November 2017

Shunsuke Goto

4

1 reference

28 November 2017

Riko Kitazawa

5

1 reference

28 November 2017

Michinori Hirata

7

1 reference

28 November 2017

Masami Shinohara

8

1 reference

28 November 2017

Shinichi Nishi

10

1 reference

28 November 2017

publication date

11 September 2013

1 reference

Journal of Clinical Hypertension

28 November 2017

published in

1 reference

28 November 2017

volume

27

1 reference

28 November 2017

issue

4

1 reference

28 November 2017

page(s)

586-595

1 reference

Prevention of diabetic nephropathy by tight target control in an asian population with type 2 diabetes mellitus: a 4-year prospective analysis

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPT160

Oxidative stress in early diabetic nephropathy: fueling the fire

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPT160

Oxidative and nitrosative stress and progression of diabetic nephropathy in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPT160

Bardoxolone methyl and kidney function in CKD with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPT160

Vitamin D, glucose tolerance and insulinaemia in elderly men

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPT160

Association of serum 25-hydroxyvitamin D with type 2 diabetes and markers of insulin resistance in a general older population in Finland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPT160

Serum 25(OH)D and type 2 diabetes association in a general population: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPT160

Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPT160

Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPT160

Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPT160

Combination therapy with paricalcitol and enalapril ameliorates cardiac oxidative injury in uremic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPT160

Effects of supplemental vitamin D and calcium on oxidative DNA damage marker in normal colorectal mucosa: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPT160

Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPT160

Administration of alfacalcidol for patients with predialysis chronic kidney disease may reduce cardiovascular disease events

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPT160

Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPT160

Effect of vitamin D supplementation on blood pressure in blacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPT160

Oral paricalcitol in the treatment of patients with CKD and proteinuria: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPT160

Suppression of renin-angiotensin gene expression in the kidney by paricalcitol

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPT160

Different effects of 22-oxacalcitriol and calcitriol on the course of experimental chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPT160

Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPT160

Combined vitamin D analog and AT1 receptor antagonist synergistically block the development of kidney disease in a model of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPT160

Anti-oxidative effect of vitamin D analog on incipient vascular lesion in non-obese type 2 diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPT160

The number of 1,25-dihydroxyvitamin D3 receptors is decreased in both intestine and kidney of genetically diabetic db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPT160

Characterization of a vitamin D receptor knockout mouse as a model of colorectal hyperproliferation and DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPT160

Increased NF-kappaB activity in fibroblasts lacking the vitamin D receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPT160

Activation of tubular epithelial cells in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPT160

High glucose induces renal mesangial cell proliferation and fibronectin expression through JNK/NF-κB/NADPH oxidase/ROS pathway, which is inhibited by resveratrol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPT160

Paricalcitol inhibits renal inflammation by promoting vitamin D receptor-mediated sequestration of NF-kappaB signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPT160

1,25-Dihydroxyvitamin D3 targeting of NF-kappaB suppresses high glucose-induced MCP-1 expression in mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPT160

Diabetic downregulation of Nrf2 activity via ERK contributes to oxidative stress-induced insulin resistance in cardiac cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPT160

A defect in Nrf2 signaling constitutes a mechanism for cellular stress hypersensitivity in a genetic rat model of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPT160

Expression profiling in squamous carcinoma cells reveals pleiotropic effects of vitamin D3 analog EB1089 signaling on cell proliferation, differentiation, and immune system regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPT160

The Nrf2 transcription factor is a positive regulator of myeloid differentiation of acute myeloid leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPT160

21 January 2018

Identifiers

DOI

10.1093/AJH/HPT160

1 reference

28 November 2017

1 reference